Clinical Trial Update: Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update on empagliflozin for preserving beta-cell function in women with recent gestational diabetes. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Gestational Diabetes | Phase 3 | Status: COMPLETED